TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $135 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 85.8%

Neg 0% Neu 85.8% Pos 0%

TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintains $135 price target.

Comments

No comments yet. Be the first!